(Q45259348)

11 December 2017

title

Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease (English)

1 reference

11 December 2017

1 reference

1 reference

Jens Teichert

1

1 reference

11 December 2017

Tina Tuemmers

2

1 reference

11 December 2017

Harald Achenbach

3

1 reference

11 December 2017

Christa Preiss

4

1 reference

11 December 2017

Robert Hermann

5

1 reference

11 December 2017

Peter Ruus

6

1 reference

11 December 2017

Rainer Preiss

7

1 reference

11 December 2017

publication date

1 March 2005

1 reference

The Journal of Clinical Pharmacology

11 December 2017

published in

1 reference

11 December 2017

volume

45

1 reference

11 December 2017

issue

3

1 reference

11 December 2017

page(s)

313-328

1 reference

Thioctic Acid and Dihydrolipoic Acid are Novel Antioxidants Which Interact With Reactive Oxygen Species

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Alpha-lipoic acid as a biological antioxidant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Neuroprotection by the metabolic antioxidant alpha-lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

The pharmacology of the antioxidant lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Idiopathic dysgeusia; an open trial of alpha lipoic acid (ALA) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Early oxidative stress in the diabetic kidney: effect of DL-alpha-lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients. Risk analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Plasma Kinetics, Metabolism, and Urinary Excretion of Alpha‐Lipoic Acid following Oral Administration in Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

High-performance liquid chromatographic assay for alpha-lipoic acid and five of its metabolites in human plasma and urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

The effect of chronic renal failure on hepatic drug metabolism and drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Lipid metabolism in peroxisomes: enzymology, functions and dysfunctions of the fatty acid alpha- and beta-oxidation systems in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004270792

21 January 2018

Identifiers

DOI

10.1177/0091270004270792

1 reference

11 December 2017

1 reference